SCHEMBL27245125

SCHEMBL27245125

O=C(O)[C@@H]1CC2(CN1C(=O)O)Oc1ccccc1NC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.38
▸ POLB P06746 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ALOX5 P09917 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 1/20 0.33
▸ GRM2 Q14416 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ CREBBP Q92793 1/20 0.32
▸ PARP1 P09874 1/20 0.31
▸ ALDH2 P05091 1/20 0.31
▸ ALDH3A1 P30838 1/20 0.31
▸ OTUD7B Q6GQQ9 2/20 0.31
▸ GRM6 O15303 1/20 0.31
▸ GAA P10253 2/20 0.30
▸ LMNA P02545 2/20 0.30
▸ MMP2 P08253 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALPL P05186 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890749 0.85 NR1H2 (0.42) MAPTPOLBHSD17B10BRD4CREBBP
SCHEMBL27244841 0.82 OTUD7B (0.50) MAPTALDH1A1GRM2BRD4CREBBP
SCHEMBL30890444 0.81 POLB (0.36) MAPTPOLBHSD17B10ALDH1A1HPGD
SCHEMBL27245195 0.80 OTUD7B (0.37) POLBALOX5ALDH1A1HPGDOTUD7B
SCHEMBL27244904 0.76 OTUD7B (0.37) OTUD7B
SCHEMBL27244814 0.75 L3MBTL1 (0.33) MAPTALDH1A1GAALMNAMEN1
SCHEMBL27244767 0.75 AKR1B1 (0.39) POLBALDH1A1HPGDOTUD7BKMT2A
SCHEMBL30890482 0.75 POLB (0.40) POLBHSD17B10BRD4CREBBPPARP1
SCHEMBL27244855 0.74 PTK2B (0.32) ALDH1A1GAA
SCHEMBL30992285 0.74 IMPDH2 (0.41) MAPTPOLBHSD17B10BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199647-A1 ANTI-VIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199647-A1 ANTI-VIRAL COMPOUNDS EIF2AK2, ZC3HAV1, HAVCR2 MAPT 1485/4885POLB 356/4885HSD17B10 1644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback